The pharmaceutical giant just extended the lifespan of one of its top drugs.

Pfizer shows steady pharmaceutical progress with oncology growth and drug protection strength, shaping healthcare dynamics ...

April 28 (Reuters) - Pfizer said on Tuesday it has settled patent disputes with three generic drugmakers over its blockbuster ...

Settlements delaying the arrival of generic versions of tafamidis will protect billions in Pfizer revenue and have ...

Pfizer Inc. (NYSE:PFE) is one of the most active US stocks to buy right now. On April 28, Pfizer entered into settlement ...

NEW YORK, N.Y. — Pfizer announced Wednesday that data shows a third dose of its COVID-19 vaccine can “strongly” boost protection against the highly transmissible delta variant. The pharmaceutical and ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. (WTVO) – A new study suggests the Pfizer and ...

A recent study suggests people may have protection from the coronavirus for years if they received the Pfizer-BioNTech or Moderna vaccine. The study was published in the journal Nature. “Overall, our ...

Add Yahoo as a preferred source to see more of our stories on Google. In today’s Health Alert, Pfizer’s Lyme vaccine shows strong protection in a phase 3 clinical trial, but misses a key study goal.